What are hypovolemia and cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definitions of Hypovolemia and Cardiomyopathy

Hypovolemia

Hypovolemia is a critical decrease in intravascular volume caused by hemorrhage, inadequate fluid intake, or external fluid loss (such as diarrhea or excessive sweating), leading to diminished venous return (preload), decreased ventricular filling, reduced stroke volume, and ultimately decreased cardiac output unless compensated by increased heart rate. 1

Pathophysiology and Clinical Context

  • Hypovolemic shock occurs when the volume depletion becomes severe enough to cause hemodynamic instability and tissue hypoperfusion 1

  • The condition results in a small, hyperdynamic, unloaded ventricle with reduced left ventricular end-diastolic area on echocardiography 1

  • In profound hypovolemia, the inferior vena cava diameter becomes small (<10 mm) with inspiratory collapse in spontaneously breathing patients 1

Common Causes in Clinical Practice

  • Hemorrhage from trauma, surgery, or gastrointestinal bleeding 1

  • Inadequate fluid intake during prolonged travel or illness 1

  • External fluid losses including traveler's diarrhea (affecting 10-40% of travelers to high-risk regions), excessive sweating in hot climates (up to 1.2 L/day fluid loss), and increased respiratory water losses during air travel (approximately 200 mL/hour) 1

  • Iatrogenic causes in heart failure patients from excessive diuretic therapy, fluid restriction, or RAAS inhibitor use 1

Clinical Manifestations

  • Fatigue, exercise intolerance, weight loss, increased heart rate 1

  • Muscle cramps, weakness, postural dizziness 1

  • Low urine volume, hypotension, lethargy, confusion 1

  • Abdominal pain in severe cases 1

Cardiomyopathy

Cardiomyopathy is a myocardial disorder in which the heart muscle is structurally and functionally abnormal in the absence of coronary artery disease, hypertension, valvular disease, or congenital heart disease sufficient to cause the observed myocardial abnormality. 1

Major Classification Categories

According to the American Heart Association, cardiomyopathies are classified into distinct morphological and functional phenotypes 2:

  • Dilated cardiomyopathy: characterized by ventricular chamber enlargement and systolic dysfunction 2, 3

  • Hypertrophic cardiomyopathy: notable for massive ventricular hypertrophy without obvious cause, affecting 1 in 500 of the general population, caused by more than 1,400 mutations in 11 or more genes encoding cardiac sarcomere proteins 1, 4, 3

  • Restrictive cardiomyopathy: demonstrates restriction to ventricular filling due to restrictive forces in the endomyocardium 2, 3

  • Arrhythmogenic right ventricular cardiomyopathy: primarily affects the right ventricle 2

  • Inflammatory cardiomyopathy: includes myocarditis and related conditions 2

Further Subdivision

  • Primary cardiomyopathies: genetic, nongenetic, and acquired forms 2

  • Secondary cardiomyopathies: myocardial involvement as part of systemic disorders such as amyloidosis, systemic sclerosis, or infiltrative diseases 2

Clinical Characteristics

  • Hypertrophic cardiomyopathy features impaired diastolic and systolic function, tendency for sudden death, familial propensity, and cardiac manifestations in approximately 80% of patients with myotonic dystrophy type 1 1, 2, 3

  • Dilated cardiomyopathy demonstrates severe systolic failure progressing to congestive heart failure, usually without familial tendency 3

  • Most patients with nonischemic cardiomyopathy have no identifiable causative factor (idiopathic dilated cardiomyopathy), though some cases relate to systemic disorders, cardiotoxic agents (alcohol, cocaine, anthracyclines), or myocardial inflammation 1

Important Clinical Pitfall

Hypovolemia can precipitate acute decompensation in cardiomyopathy patients, particularly in hypertrophic cardiomyopathy where volume depletion combined with catecholamine therapy can cause severe left ventricular outflow tract obstruction and hemodynamic collapse 4, 5, 6. During anesthesia or critical illness in these patients, it is essential to prevent hypovolemia and maintain adequate preload 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Myopathy Classification and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Perioperative management for patients with hypertrophic cardiomyopathy].

Masui. The Japanese journal of anesthesiology, 2014

Research

Takotsubo cardiomyopathy: a hidden enemy of the hypovolemic patient?

The American journal of emergency medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.